APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 213 filers reported holding APELLIS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $527,463 | -58.8% | 13,866 | -1.3% | 0.01% | -58.8% |
| Q2 2023 | $1,279,682 | +258.3% | 14,047 | +159.4% | 0.02% | +240.0% |
| Q1 2023 | $357,173 | +28.7% | 5,415 | +0.9% | 0.01% | +25.0% |
| Q4 2022 | $277,631 | -22.7% | 5,369 | +2.2% | 0.00% | -42.9% |
| Q3 2022 | $359,000 | +62.4% | 5,255 | +7.6% | 0.01% | +75.0% |
| Q2 2022 | $221,000 | -1.8% | 4,885 | +37.4% | 0.00% | 0.0% |
| Q2 2021 | $225,000 | – | 3,556 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 2,503,059 | $170,959,000 | 29.50% |
| ACUTA CAPITAL PARTNERS, LLC | 554,000 | $37,838,000 | 16.29% |
| Avoro Capital Advisors LLC | 10,125,000 | $691,538,000 | 12.78% |
| Sio Capital Management, LLC | 507,700 | $34,676,000 | 11.02% |
| Logos Global Management LP | 1,300,000 | $88,790,000 | 10.92% |
| EcoR1 Capital, LLC | 5,183,431 | $354,028,000 | 10.45% |
| Cormorant Asset Management, LP | 1,478,000 | $100,947,000 | 7.06% |
| Finepoint Capital LP | 266,090 | $18,174,000 | 5.98% |
| Ghost Tree Capital, LLC | 275,000 | $18,783,000 | 5.27% |
| Boxer Capital, LLC | 1,303,700 | $89,043,000 | 5.01% |